跳至主要内容
临床试验/NL-OMON24620
NL-OMON24620尚未招募不适用

Intra-articular injection of adipose-derived stromal vascular fraction in osteoarthritis of the temporomandibular joint

MCG0 个研究点目标入组 40 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Age between 18-70 years
  • Chronic nociceptive pain in the TMJ region, aggravated by protrusion, maximal mouth opening, lateral excursions and/or chewing of at least 2 months
  • Wilkes stages III or IV (internal derangement)
  • Limited maximal interincisal opening (< 35 mm and > 15 mm)
  • Pain still present after two weeks of a NSAID (i.e. ibuprofen 600 mg three times daily, or diclophenac 50 mg 3td, or napoxen 500 mg 2 td)
  • Pain disappears after diagnostic intra-articular injection

排除标准

  • Edentulous (no dentition)
  • Previous treatments acting on cartilage or bone metabolism (eg, oral or intravenous bisphosphonates <1 year previously, strontium ranelate or teriparatide or raloxifene <7 days prior to selection, and oral glucosamine =1500 mg/day and chondroitin sulphate <3 months previously)
  • Concurrent use of anti-inflammatory medication, steroids, muscle relaxants or antidepressants
  • Previous TMJ traumas and fractures
  • Previous TMJ surgeries, previous intra-articular injections < 1 year before
  • Bilateral severe TMJ derangements
  • Bony or fibrotic ankylosis of the TMJ
  • Known history of diabetes mellitus type 1 or 2
  • Known history of HIV
  • Serious systemic diseases, rheumatic disease or infectious/inflammatory diseases affecting the skin of the area of the TMJ
  • Coagulation disorders

研究者

发起方
MCG

相似试验

Intra-articular injection of adipose-derived stromal... | 临床试验